Raygent.com provides financial and strategic advisory services based upon over 25 years experience in the industry on the management side with in-depth knowledge of technology and business models. Raygent provides consulting services to early stage life science start-ups at no charge for a limited time period.
The Raygent life science market report has been published since 2005 including the “Guide to Biotechnology Investing “published originally in 2004. All previous articles beginning 2009 are available for viewing on the website.
We cannot cover all life science news events and analysis of Companies but you should do what we do. Set-up your portfolio of selected stocks on Seeking Alpha and they will send you significant news events.
——–
Raygent equity portfolio picks are based on a proprietary model that includes technology analysis, new product and pipeline review, financial analysis and management strength.
——–
Rod Raynovich, Founder, Raygent Associates
Rod Raynovich is the founder of Raygent.com provides business development and strategic marketing services in the life science and in vitro diagnostics sector. He publishes his market report on the life science markets at www.raygent.com.
Rod Raynovich is an experienced entrepreneur and biotech investor with a focus in vaccines, life science tools, clinical diagnostics (IVDs) and biopharmaceuticals. Prior to starting Raygent, he was a technology transfer officer for UCLA and he has held various executive positions in the biotech and pharmaceutical industry, including senior positions at NASDAQ listed medical device companies. He has also been involved in a number of early stage ventures in biotech and diagnostics. Prior to that Mr. Raynovich held management positions at JNJ and Abbott.